LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 83 filers reported holding LION BIOTECHNOLOGIES INC in Q2 2016. The put-call ratio across all filers is 4.91 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,545,000 | +13.3% | 207,370 | +5.7% | 0.00% | +100.0% |
| Q4 2016 | $1,364,000 | -10.8% | 196,150 | +5.6% | 0.00% | -50.0% |
| Q3 2016 | $1,529,000 | +18.4% | 185,667 | +16.5% | 0.00% | 0.0% |
| Q2 2016 | $1,291,000 | +63.2% | 159,377 | +2.4% | 0.00% | +100.0% |
| Q1 2016 | $791,000 | -32.5% | 155,699 | +2.6% | 0.00% | -50.0% |
| Q4 2015 | $1,172,000 | +39.5% | 151,698 | +4.0% | 0.00% | +100.0% |
| Q3 2015 | $840,000 | -32.9% | 145,827 | +6.9% | 0.00% | -50.0% |
| Q2 2015 | $1,252,000 | – | 136,464 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,232,416 | $26,183,000 | 12.58% |
| Avoro Capital Advisors LLC | 4,338,557 | $35,142,000 | 7.81% |
| FRAZIER MANAGEMENT LLC | 774,720 | $6,275,000 | 5.00% |
| Broadfin Capital, LLC | 3,170,759 | $25,683,000 | 2.50% |
| Perceptive Advisors | 3,611,976 | $29,257,000 | 2.03% |
| Ghost Tree Capital, LLC | 700,000 | $5,670,000 | 1.64% |
| Opaleye Management Inc. | 260,000 | $2,106,000 | 1.41% |
| Rhenman & Partners Asset Management AB | 650,000 | $5,265,000 | 0.94% |
| QVT Financial LP | 1,598,309 | $12,946,000 | 0.89% |
| Cormorant Asset Management, LP | 505,941 | $4,098,000 | 0.58% |